title: Estrogen and cyproterone acetate combination-induced autoimmune hepatitis.
authors.forename: Sabite
authors.initials: S
authors.lastname: Kacar
authors.forename: Meral
authors.initials: M
authors.lastname: Akdogan
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Koşar
authors.forename: Erkan
authors.initials: E
authors.lastname: Parlak
authors.forename: Nurgul
authors.initials: N
authors.lastname: Sasmaz
authors.forename: Perihan
authors.initials: P
authors.lastname: Oguz
authors.forename: Gulden
authors.initials: G
authors.lastname: Aydog
mesh_terms: D000293:Adolescent; D000726:Androgen Antagonists / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine; D017373:Cyproterone Acetate / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D045166:Estradiol Congeners / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D019693:Hepatitis, Autoimmune / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008111:Liver Function Tests; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D000893:Anti-Inflammatory Agents; D045166:Estradiol Congeners; D007166:Immunosuppressive Agents; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; D011239:Prednisolone; D001379:Azathioprine